Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Roche Media News directly as they happen.
Follow now 321 followers
Last updated 1 day ago
1 day ago
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
8 days ago
Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first...
11 days ago
Combination reduced the risk of disease progression or death by 46% and...
11 days ago
Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
12 days ago
Basel, 1 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
14 days ago
Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy...
20 days ago
OCREVUS subcutaneous maintains consistent benefit-risk profile after two years New late-breaking data...
22 days ago
evERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in...
25 days ago
Lunsumio provides high and long-lasting response rates, with approximately two-thirds of patients...
26 days ago
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe...
about 1 month ago
In AVONELLE-X, the largest long-term extension trial in nAMD, disease control and...
about 1 month ago
Susvimo is under review with the EMA and once approved will be...